GIVATAYIM, Israel, Nov. 10, 2026 /PRNewswire/ -- Eocene Ltd. (NASDAQ: EOCN) ("Eocene" or the "Company") today announced that its wholly owned subsidiary, Colospan Ltd. ("Colospan"), has entered into its first European commercial distribution agreement for its CG-100 device with Hospital Line SA ("Hospital Line"). Under the agreement, Hospital Line has been granted exclusive rights to market, sell and distribute CG-100 in Greece and Cyprus. Colospan intends for the agreement to serve as a foundation for the potential further commercial expansion of CG-100 into additional European markets. The planned commercial launch of CG-100 in Greece and Cyprus is expected to proceed in parallel with Colospan's ongoing U.S. pivotal study of CG-100.